Cita APA (7a ed.)
Ramesh, P. L., Khandelwal, P., Lakshmy, R., Sinha, A., Bagga, A., & Hari, P. (2023). Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2–5. Pediatric Nephrology, 38(8), 2763-2771.
Cita Chicago Style (17a ed.)
Ramesh, Punitha Lakxmi, Priyanka Khandelwal, R. Lakshmy, Aditi Sinha, Arvind Bagga, y Pankaj Hari. "Short-term Safety and Efficacy of Escalating Doses of Atorvastatin for Dyslipidemia in Children with Predialysis Chronic Kidney Disease Stage 2–5." Pediatric Nephrology 38, no. 8 (2023): 2763-2771.
Cita MLA (9a ed.)
Ramesh, Punitha Lakxmi, et al. "Short-term Safety and Efficacy of Escalating Doses of Atorvastatin for Dyslipidemia in Children with Predialysis Chronic Kidney Disease Stage 2–5." Pediatric Nephrology, vol. 38, no. 8, 2023, pp. 2763-2771.
Precaución: Estas citas no son 100% exactas.